Merit Financial Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.06M | Buy |
64,678
+1,821
| +3% | +$147K | 0.03% | 433 |
|
|
2026
Q1 | $5.45M | Sell |
62,857
-9,389
| -13% | -$899K | 0.04% | 367 |
|
|
2025
Q4 | $6.94M | Buy |
72,246
+6,087
| +9% | +$591K | 0.06% | 270 |
|
|
2025
Q3 | $6.3M | Buy |
66,159
+9,124
| +16% | +$839K | 0.06% | 262 |
|
|
2025
Q2 | $4.97M | Buy |
57,035
+15,561
| +38% | +$1.32M | 0.06% | 279 |
|
|
2025
Q1 | $3.73M | Buy |
41,474
+18,204
| +78% | +$1.63M | 0.06% | 276 |
|
|
2024
Q4 | $1.86M | Buy |
23,270
+17,831
| +328% | +$1.54M | 0.03% | 369 |
|
|
2024
Q3 | $490K | Sell |
5,439
-10,441
| -66% | -$878K | 0.01% | 560 |
|
|
2024
Q2 | $1.25M | Buy |
15,880
+2,045
| +15% | +$168K | 0.03% | 360 |
|
|
2024
Q1 | $1.13M | Buy |
13,835
+4,422
| +47% | +$377K | 0.03% | 371 |
|
|
2023
Q4 | $775K | Buy |
9,413
+194
| +2% | +$14.8K | 0.02% | 377 |
|
|
2023
Q3 | $722K | Buy |
9,219
+1,104
| +14% | +$92.4K | 0.02% | 381 |
|
|
2023
Q2 | $715K | Buy |
8,115
+2,525
| +45% | +$217K | 0.02% | 387 |
|
|
2023
Q1 | $451K | Sell |
5,590
-1,903
| -25% | -$155K | 0.02% | 427 |
|
|
2022
Q4 | $582K | Buy |
7,493
+1,544
| +26% | +$125K | 0.02% | 390 |
|
|
2022
Q3 | $480K | Sell |
5,949
-6,460
| -52% | -$581K | 0.02% | 365 |
|
|
2022
Q2 | $1.11M | Buy |
12,409
+10,332
| +497% | +$1.05M | 0.03% | 241 |
|
|
2022
Q1 | $230K | Sell |
2,077
-4,918
| -70% | -$520K | 0.01% | 342 |
|
|
2021
Q4 | $724K | Buy |
6,995
+21
| +0.3% | +$2.43K | 0.07% | 135 |
|
|
2021
Q3 | $874K | Buy |
6,974
+109
| +2% | +$14.1K | 0.09% | 111 |
|
|
2021
Q2 | $852K | Buy |
6,865
+85
| +1% | +$10.7K | 0.08% | 110 |
|
|
2021
Q1 | $801K | Buy |
6,780
+388
| +6% | +$45.5K | 0.08% | 107 |
|
|
2020
Q4 | $749K | Sell |
6,392
-159
| -2% | -$17.5K | 0.07% | 104 |
|
|
2020
Q3 | $681K | Buy |
6,551
+246
| +4% | +$24.7K | 0.06% | 114 |
|
|
2020
Q2 | $578K | Sell |
6,305
-774
| -11% | -$74.2K | 0.06% | 114 |
|
|
2020
Q1 | $638K | Buy |
7,079
+995
| +16% | +$106K | 0.07% | 101 |
|
|
2019
Q4 | $690K | Buy |
6,084
+1,639
| +37% | +$180K | 0.06% | 110 |
|
|
2019
Q3 | $483K | Buy |
4,445
+108
| +2% | +$11.3K | 0.05% | 86 |
|
|
2019
Q2 | $422K | Buy |
4,337
+155
| +4% | +$14.2K | 0.05% | 75 |
|
|
2019
Q1 | $380K | Buy |
4,182
+136
| +3% | +$12.2K | 0.05% | 88 |
|
|
2018
Q4 | $368K | Buy |
4,046
+37
| +0.9% | +$3.46K | 0.06% | 65 |
|
|
2018
Q3 | $394K | Sell |
4,009
-87
| -2% | -$8.04K | 0.06% | 68 |
|
|
2018
Q2 | $350K | Buy |
4,096
+278
| +7% | +$23.2K | 0.06% | 77 |
|
|
2018
Q1 | $306K | Buy |
3,818
+66
| +2% | +$5.44K | 0.06% | 84 |
|
|
2017
Q4 | $302K | Buy |
+3,752
| New | +$300K | 0.06% | 85 |
|
Other funds holding MDT
Merit Financial Group's MDT Position: Q2 2026 in Review
Merit Financial Group increased its Medtronic (MDT) stake by 2.9% in Q2 2026, buying an estimated $147K and bringing the position to 64,678 shares worth $5.06M. The position accounts for 0.03% of the portfolio, ranked #433.
Merit Financial Group first reported a position in MDT in Q4 2017 and has held it in 35 quarters since. The position peaked at $6.94M in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Merit Financial Group held 64,678 shares of Medtronic worth $5.06M as of Q2 2026.
- Merit Financial Group bought 1,821 Medtronic shares in Q2 2026, an estimated $147K.
- Medtronic made up 0.03% of Merit Financial Group's portfolio in Q2 2026, its #433 holding.
- Merit Financial Group first reported a position in Medtronic in Q4 2017 and has held it in 35 quarters since.
- Merit Financial Group's Medtronic position peaked at $6.94M in Q4 2025.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.